Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics.
Rexach JE, Cheng Y, Chen L, Polioudakis D, Lin LC, Mitri V, Elkins A, Han X, Yamakawa M, Yin A, Calini D, Kawaguchi R, Ou J, Huang J, Williams C, Robinson J, Gaus SE, Spina S, Lee EB, Grinberg LT, Vinters H, Trojanowski JQ, Seeley WW, Malhotra D, Geschwind DH.
Cell. 2024 Oct 3;187(20):5753-5774.e28. doi: 10.1016/j.cell.2024.08.019. Epub 2024 Sep 11.
PMID:39265576
Thyrotoxic myopathy: research status, diagnosis, and treatment.
Cui H, Zhang X.
Endokrynol Pol. 2022;73(1):157-162. doi: 10.5603/EP.a2022.0004. Epub 2022 Feb 4.
PMID:35119093
Endocrine myopathies.
Kendall-Taylor P, Turnbull DM.
Br Med J (Clin Res Ed). 1983 Sep 10;287(6394):705-8. doi: 10.1136/bmj.287.6394.705.
PMID:6412791
Botulinum toxin paralysis of adult monkey extraocular muscle. Structural alterations in orbital, singly innervated muscle fibers.
2014 Apr 17 [updated 2021 Jun 24]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:24741716
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.
Quattrone A, Franzmeier N, Huppertz HJ, Klietz M, Roemer SN, Boxer AL, Levin J, Höglinger GU; AL‐108‐231 Investigators, the Tauros MRI Investigators, the PASSPORT Study Group, the DESCRIBE‐PSP Group.
Mov Disord. 2024 Aug;39(8):1329-1342. doi: 10.1002/mds.29866. Epub 2024 Jun 2.